AI ScreeningAI ChatPricing
  1. JP-listed companies
  2. Momotaro-Gene Inc.
  3. Financials
  4. Earnings per share

Momotaro-Gene Inc.【JP:E33052】

Market cap
P/E ratio
SummaryFinancialsDividendsHistoryWorkforce
Period EndEarnings per share (JPY)YoY (%)
Mar 31, 2023-18,897.4-4.20%
Mar 31, 2022-19,725.2-33.25%
Mar 31, 2021-29,552.7+24.09%
Mar 31, 2020-23,816-35.05%
Mar 31, 2019-36,666.5+12.11%
Mar 31, 2018-32,704.4-14.14%
Mar 31, 2017-38,092.2+112.75%
Mar 31, 2016-17,904.9+63.98%
Mar 31, 2015-10,919.2+83.19%
Mar 31, 2014-5,960.5-14.35%
Mar 31, 2013-6,959.1+55.19%
Mar 31, 2012-4,484.2-84.37%
Mar 31, 2011-28,693.2-24.68%
Mar 31, 2010-38,094.2+12.18%
Mar 31, 2009-33,957.7+163.98%
Mar 31, 2008-12,863.7

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating expenses Operating income Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSAdjusted EPSDividend payout ratio (%)Dividend per shareEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)